The Germany legal cannabis market size is anticipated to reach USD 9.66 billion by 2033, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 18.9% from 2025 to 2033. Factors such as rising social acceptance of cannabis, growing medical applications of cannabis, increasing R&D & technological innovation, and the introduction of new cultivation technologies are expected to drive the cannabis industry in the country. For instance, in February 2024, according to data published in Reuters, 4.5 million individuals are estimated to use cannabis in Germany.
Furthermore, favorable government initiatives and reimbursement policies fuel the market growth. For instance, according to data published by the Federal Union of German Associations of Pharmacists (ABDA), the number of prescriptions for medical cannabis for Statutory Health Insurance (SHI)-insured patients in Germany was 338,500 in 2022. Furthermore, according to the same source, 14,840 Kg of cannabis was delivered to pharmacies for medicinal purposes in 2022.
Moreover, growing awareness among people regarding the therapeutic applications of cannabis and the launch of online cannabis prescription platforms drive market growth. For instance, in September 2023, Cantourage Group SE, a Berlin-based company, introduced Telecan, a telemedicine platform for medical cannabis, under the guidance of Florian Wesemann, a medical doctor. The platform offers a simple and convenient way for potential patients to access cannabis therapy.
In recent years, there has been a significant rise in the usage of cannabis and its derivatives in Germany. The medical application of CBD has gained immense popularity, leading to the development of policies for its distribution and use by the government. Moreover, conferences and various events being organized for cannabis industry leaders drive market growth. For instance, the International Cannabis Business Conference was to be held in Berlin in April 2024, Germany’s biggest annual gathering of influential political and cannabis business leaders.
The cannabis industry has witnessed the development of new techniques and technologies that aid in its cultivation, and these advancements are expected to boost market growth. The demand for technologically advanced cannabis production has led to the optimization of resources by cultivators. This, coupled with the increased utilization of hemp and marijuana in various sectors, such as personal care & cosmetics, pharmaceuticals, nutraceuticals, and food, & beverages, has impelled market growth. In addition, the use of cannabis and its derivatives by various businesses as a raw material for manufacturing products is projected to drive market growth over the forecast period.
Request a free sample copy or view report summary: Germany Legal Cannabis Market Report
By source, the hemp segment dominated the market with the highest revenue share of 74.68% in 2024. Hemp covers an extensive range of products, including supplements, nutritional powders, beverages, protein & nutrition bars, animal feed, and pet food.
By derivatives, the CBD segment dominated the market with the largest revenue share of 66.46% in 2024. CBD is the non-psychoactive compound found in the cannabis plant, and its adoption is increasing for a wide range of health benefits.
The medical segment dominated the market with a revenue share of 73.30% in 2024, driven by the country’s progressive regulations that allow patients with chronic and severe health conditions to access cannabis-based treatments.
Grand View Research has segmented the Germany legal cannabis market report based on source, derivatives, and end use:
Germany Legal Cannabis Source Outlook (Revenue, USD Million, 2021 - 2033)
.Hemp
Hemp oil
Industrial Hemp
Marijuana
Flower
Oil and Tinctures
Germany Legal Cannabis Derivatives Outlook (Revenue, USD Million, 2021 - 2033)
CBD
THC
Others
Germany Legal Cannabis End Use Type Outlook (Revenue, USD Million, 2021 - 2033)
Industrial Use
Medical Use
Chronic Pain
Depression and Anxiety
Arthritis
Post Traumatic Stress Disorder (PTSD)
Cancer
Migraines
Epilepsy
Alzheimers's
Multiple Sclerosis
AIDS
Amyotrophic Lateral Sclerosis
Tourettes
Diabetes
Parkinson's
Glaucoma
Others
Recreational Use
List Of Key Players in the Germany Legal Cannabis Market
The Cronos Group
Organigram Holding, Inc
Tilray Brands
Canopy Growth Corporation
Aurora Cannabis
SynBiotic
Cansativa GmbH
DEMECAN
Four 20 Pharma
Avextra Pharma GmbH
"The quality of research they have done for us has been excellent..."